PI
NVO

PEAK6 Investments’s Novo Nordisk NVO Stock Holding History

PEAK6 Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$12.3M Buy
103,700
+60,400
+139% +$8.06M 0.03% 479
2024
Q2 		$6.18M Sell
43,300
-28,600
-40% -$3.79M 0.02% 737
2024
Q1 		$9.23M Buy
+71,900
New +$8.56M 0.02% 555
2023
Q4 		– Sell
-30,000
Closed -$2.73M – 4652
2023
Q3 		$2.73M Buy
30,000
+15,000
+100% +$1.32M 0.01% 1122
2023
Q2 		$1.21M Buy
+15,000
New +$1.23M 0.01% 1577
2023
Q1 		– Sell
-33,400
Closed -$2.26M – 4762
2022
Q4 		$2.26M Buy
33,400
+9,600
+40% +$563K 0.01% 1239
2022
Q3 		$1.19M Buy
23,800
+8,800
+59% +$471K 0.01% 2028
2022
Q2 		$1.21M Buy
+15,000
New +$832K ﹤0.01% 2881
2021
Q4 		– Sell
-165,800
Closed -$7.96M – 5598
2021
Q3 		$7.96M Sell
165,800
-43,000
-21% -$2.08M 0.02% 839
2021
Q2 		$8.75M Buy
208,800
+12,200
+6% +$473K 0.02% 764
2021
Q1 		$6.63M Sell
196,600
-101,200
-34% -$3.6M 0.02% 864
2020
Q4 		$10.4M Buy
297,800
+293,200
+6,374% +$10.1M 0.02% 658
2020
Q3 		$160K Sell
4,600
-3,800
-45% -$127K ﹤0.01% 3629
2020
Q2 		$275K Sell
8,400
-3,200
-28% -$102K ﹤0.01% 3163
2020
Q1 		$349K Sell
11,600
-18,400
-61% -$548K ﹤0.01% 2376
2019
Q4 		$868K Hold
30,000
– – ﹤0.01% 1613
2019
Q3 		$776K Sell
30,000
-132,000
-81% -$3.34M ﹤0.01% 1952
2019
Q2 		$4.13M Buy
162,000
+132,000
+440% +$3.26M 0.03% 821
2019
Q1 		$785K Buy
+30,000
New +$737K ﹤0.01% 2044

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PEAK6 Investments's NVO Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Novo Nordisk (NVO) in Q3 2024: 66,149 shares worth $7.88M. The stake represents 0.02% of the portfolio and ranks #690 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in NVO as recently as Q3 2023.

PEAK6 Investments first reported a position in NVO in Q1 2019 and has held it in 12 quarters since. 1,784 funds tracked by Wall St. Rank hold NVO as of Q3 2024.

  • PEAK6 Investments held 66,149 shares of Novo Nordisk worth $7.88M as of Q3 2024.
  • Novo Nordisk was a new PEAK6 Investments position in Q3 2024.
  • Novo Nordisk made up 0.02% of PEAK6 Investments's portfolio in Q3 2024, its #690 holding.
  • PEAK6 Investments first reported a position in Novo Nordisk in Q1 2019 and has held it in 12 quarters since.
  • 1,784 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.